1.
Bull Exp Biol Med
; 164(4): 569-575, 2018 Mar.
Artículo
en Inglés
| MEDLINE
| ID: mdl-29504105
RESUMEN
We analyzed previously generated stable monocyte-derived cell line carrying mutation JAK2 V617F. Evaluation of the expression of pro- and antifibrotic factors revealed changes in the production of MMPs and their inhibitors, growth factors, galectin-3, and pentraxin 3 in cells carrying mutation JAK2 in comparison with control non-modified cells.